Skip to content

Partner with Us

Designed to help you achieve your antibody
discovery, design and development milestones

De Novo Discovery

We perform antigen-independent, de novo design by creating target-specific antibody designs using as little as a protein target sequence and your desired target-product profile. We can deliver antibodies with tailor-engineered characteristics in any number of formats, including target-specific display libraries and recombinant panels.

partner_de novo
partner_ab engineering

Antibody Engineering & Optimization

We use selected antibodies to perform computational antibody engineering, generating antibody variants that correlate to your target-product profile. We also provide a wide variety of solutions to rescue or improve an antibody depending on your needs (e.g. humanization, cross-reactivity, developability, affinity optimization, immunogenicity, patentability, and biological stability). Finally, we can construct antibody-antigen bound structure models at accuracy levels that exceed state-of-the-art protein prediction algorithms.

Biobetters

With known therapeutically relevant targets, it is often challenging to create new intellectual property. We analyze known targets and perform in silico generation of novel antibodies that preserve specificity to the target. Then we characterize and scan for developability and patentability. The result is new intellectual property to validated targets with the potential to become biobetters.

partner_biobetter

Benefits of Working with EVQLV

We continuously innovate and enhance our tech platform to more accurately predict relevant drug development factors. We welcome the opportunity to explore research or development collaborations.

Q Logo webp

Easy Integration

EVQLV's proprietary technology is format-agnostic. We can work with any antibody format - from VHH single domain nanobodies to IgGs.

Q Logo webp

Range of Offerings

We identify and map epitopes, reformat antibodies, perform negative selection, and screen existing antibody pipelines for developability.

Q Logo webp

Better Identification

We move beyond sequence identity and select antibodies of sufficient breadth in epitope coverage and structural diversity.

Q Logo webp

Flexible Partnerships

We offer flexible agreements that include any combination of de novo discovery, protein engineering, and lead optimization.

Q Logo webp

Patent Pre-Search

Combining your antibody with our platform, we can expand the number of target-specific antibodies, resulting in stronger IP portfolios.

CRO Partnerships

We establish strategic partnerships with CROs and service providers who can provide reliable and innovative offerings that complement our tech platform capabilities.

partner_CRO
partner_academic collab
partner_data

Academic Collaborations & Data Partnerships

We collaborate with academic institutions on research projects that could benefit from our technology and expertise.

We also welcome conversations on data sharing and licensing partnerships.